-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Clinical trials in neglected tropical diseases: interview with Moses Bockarie
Moses Bockarie
Interview: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Reassessment of the dysplastic nevus concept in the 21st century:a proposal for a two-tiered system of classification
Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson ,Clay J Cockerell
Editorial: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
Positive Phase III trial results of pomalidomide in addition to low-dose dexamethasone suggest significant improvements for relapsed or refractory multiple myeloma patients
Isaac Bruce
News and Views: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
The European network for Translational Research in Atrial Fibrillation
Stephane Hatem, Ulrich Schotten, Stephan Rohr, Dobromir Dobrev, Ursula Ravens, Andreas Goette, Burkert Pieske, Jens Kockskamper, Uwe Lendeckel, Barbara Casadei,Paulus Kirchhof, Frank Ulrich Muller, Pierre Jais, Ali Oto,John A Camm
Research Update: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Cladribine in the treatment of multiple sclerosis
Karen Schreiber, Per Soelberg Sorensen
Review Article: Clinical Investigation
-
Cladribine in the treatment of multiple sclerosis
Karen Schreiber, Per Soelberg Sorensen
Review Article: Clinical Investigation
-
Cladribine in the treatment of multiple sclerosis
Karen Schreiber, Per Soelberg Sorensen
Review Article: Clinical Investigation
-
Cladribine in the treatment of multiple sclerosis
Karen Schreiber, Per Soelberg Sorensen
Review Article: Clinical Investigation
-
Cladribine in the treatment of multiple sclerosis
Karen Schreiber, Per Soelberg Sorensen
Review Article: Clinical Investigation
-
Cladribine in the treatment of multiple sclerosis
Karen Schreiber, Per Soelberg Sorensen
Review Article: Clinical Investigation